The challenge of diagnosing interstitial lung disease by HRCT: state of the art and future perspectives

This publication has 12 references indexed in Scilit:

• Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society
  The Lancet Respiratory Medicine, 2020
• Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2019
• Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
  New England Journal of Medicine, 2019
• Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis
  Scientific Reports, 2019
• Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
  New England Journal of Medicine, 2019
• Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
  American Journal of Respiratory and Critical Care Medicine, 2018
• Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
  The Lancet Respiratory Medicine, 2018
• Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist
  La radiologia medica, 2017
• Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study
  The Lancet Respiratory Medicine, 2016
• Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease
  BMC Medicine, 2015